Insights

Strategic Partnerships There is a recent pattern of collaboration with medical distributors and partners (e.g., Proximo Medical) to expand US market access for COBRA PzF nanocoated coronary stents, indicating potential sales opportunities through channel partnerships and co-marketing arrangements.

Clinical Validation The COBRA PzF nanocoated stent has prior clinical data and trial milestones (Shield trial results) that support safety and efficacy, which can be leveraged to drive hospital procurement discussions and accelerate adoption in interventional cardiology programs.

Product Differentiation Polyzene F nanocoating technology positions the company with a unique value proposition in the stent market; sales tactics can emphasize coating advantages for complex patient cases and potential reductions in complications to win competitive bids.

Growth Readiness With a focused product lineup and leadership additions to drive near-term growth, there is potential for targeted outreach to mid-to-large hospital networks and cath labs seeking innovative devices to bolster their interventional cardiology portfolios.

Financial Levers Revenue range and founder-funded scale suggest opportunities to pursue multi-year contracting, bundled procurement, or strategic investment discussions with large medtech distributors and health systems looking for innovative, differentiated coronary solutions.

Similar companies to CeloNova BioSciences, Inc.

CeloNova BioSciences, Inc. Tech Stack

CeloNova BioSciences, Inc. uses 8 technology products and services including SOLIDWORKS, WordPress, Microsoft 365, and more. Explore CeloNova BioSciences, Inc.'s tech stack below.

Media & News

CeloNova BioSciences, Inc.'s Email Address Formats

CeloNova BioSciences, Inc. uses at least 2 email formats:
CeloNova BioSciences, Inc. Email FormatsExamplePercentage
FLast@celonova.comJDoe@celonova.com
98%
FMiddleLast@celonova.comJMichaelDoe@celonova.com
2%

Frequently Asked Questions

What is CeloNova BioSciences, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact CeloNova BioSciences, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is CeloNova BioSciences, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
CeloNova BioSciences, Inc.'s official website is celonova.com and has social profiles on LinkedIn.

How much revenue does CeloNova BioSciences, Inc. generate?

Minus sign iconPlus sign icon
As of July 2026, CeloNova BioSciences, Inc.'s annual revenue is estimated to be $1M - $10M.

What is CeloNova BioSciences, Inc.'s NAICS code?

Minus sign iconPlus sign icon
CeloNova BioSciences, Inc.'s NAICS code is 33911 - Medical Equipment and Supplies Manufacturing.

How many employees does CeloNova BioSciences, Inc. have currently?

Minus sign iconPlus sign icon
As of July 2026, CeloNova BioSciences, Inc. has approximately 51 employees across 3 continents, including North America, Europe and Africa. Key team members include Executive Assistant To Chief Executive Officer: P. F., Area Sales Director: D. H. and Senior Director Marketing And Commercialization: M. B. Explore CeloNova BioSciences, Inc.'s employee directory with LeadIQ.

What industry does CeloNova BioSciences, Inc. belong to?

Minus sign iconPlus sign icon
CeloNova BioSciences, Inc. operates in the Medical Devices industry.

What technology does CeloNova BioSciences, Inc. use?

Minus sign iconPlus sign icon
CeloNova BioSciences, Inc.'s tech stack includes SOLIDWORKS, WordPress, Microsoft 365, Font Awesome, Twemoji, Google Cloud, PHP and Nginx.

What is CeloNova BioSciences, Inc.'s email format?

Minus sign iconPlus sign icon
CeloNova BioSciences, Inc.'s email format typically follows the pattern of FLast@celonova.com. Find more CeloNova BioSciences, Inc. email formats with LeadIQ.

How much funding has CeloNova BioSciences, Inc. raised to date?

Minus sign iconPlus sign icon
As of July 2026, CeloNova BioSciences, Inc. has raised $21M in funding. The last funding round occurred on Nov 30, 2018.

When was CeloNova BioSciences, Inc. founded?

Minus sign iconPlus sign icon
CeloNova BioSciences, Inc. was founded in 2000.
CeloNova BioSciences, Inc. logo

CeloNova BioSciences, Inc.

Medical DevicesTexas, United States51-200 Employees

CeloNova BioSciences, Inc. is a mid-sized medical device company based in San Antonio, Texas, focused on cardiovascular solutions. Its core offering centers on the COBRA PzF NanoCoated coronary stent, which uses a proprietary Polyzene-F nanocoating to modify the stent surface. The company develops, manufactures, and markets devices for cardiovascular care on a global scale.
A 2020 partnership with Proximo Medical expanded access to the COBRA PzF stent in select U.S. markets. Historically, the company was acquired by Boston Scientific in 2015.

Section iconCompany Overview

Phone number
NAICS Code
33911 - Medical Equipment and Supplies Manufacturing
Founded
2000
Employees
51-200

Section iconFunding & Financials

  • $21M

    CeloNova BioSciences, Inc. has raised a total of $21M of funding over 3 rounds. Their latest funding round was raised on Nov 30, 2018 as a Venture Round.

  • $1M - $10M

    CeloNova BioSciences, Inc.'s revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.